Kodiak Sciences (KOD) Research & Development (2017 - 2026)
Kodiak Sciences (KOD) posted Research & Development of $48.5 million for Q1 2026, up 6.71% on a QoQ basis from $45.5 million in Q4 2025, and up 11.23% year-over-year from $43.6 million in Q1 2025.
Kodiak Sciences (KOD) Research & Development (2017 - 2026) Analysis & Trends
Kodiak Sciences' Research & Development history runs 10 years deep, the most recent figure standing at $48.5 million for Q1 2026.
- Quarterly Research & Development rose 11.23% year-over-year to $48.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $187.3 million (up 33.95% YoY) and the FY2025 annual result came in at $182.4 million, up 44.63% from the prior year.
- Research & Development was $48.5 million for Q1 2026 at Kodiak Sciences, up from $45.5 million in the prior quarter.
- Across five years, Research & Development topped out at $76.2 million in Q1 2022 and bottomed at $29.9 million in Q1 2024.
- A 5-year average of $48.9 million and a median of $46.6 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 88.85% — and 2024, when it plunged 51.44%.
- Kodiak Sciences' Research & Development stood at $56.0 million in 2022, then declined by 16.73% to $46.6 million in 2023, then sank by 31.86% to $31.8 million in 2024, then jumped by 43.19% to $45.5 million in 2025, then increased by 6.71% to $48.5 million in 2026.
- Business Quant data shows KOD's Research & Development at $48.5 million in Q1 2026, $45.5 million in Q4 2025, and $50.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Kodiak Sciences | 2.56 Bn | 2.56 Bn | - | 48.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.55 Mn |
| Dec 31, 2025 | 45.49 Mn |
| Sep 30, 2025 | 50.48 Mn |
| Jun 30, 2025 | 42.76 Mn |
| Mar 31, 2025 | 43.64 Mn |
| Dec 31, 2024 | 31.77 Mn |
| Sep 30, 2024 | 31.88 Mn |
| Jun 30, 2024 | 32.51 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 46.63 Mn |
| Sep 30, 2023 | 36.19 Mn |
| Jun 30, 2023 | 66.96 Mn |
| Mar 31, 2023 | 56.52 Mn |
| Dec 31, 2022 | 55.99 Mn |
| Sep 30, 2022 | 61.68 Mn |
| Jun 30, 2022 | 73.74 Mn |
| Mar 31, 2022 | 76.18 Mn |
| Dec 31, 2021 | 75.60 Mn |
| Sep 30, 2021 | 56.00 Mn |
| Jun 30, 2021 | 45.40 Mn |